When melanoma cells were treated with EGCG and IFN-γ simultaneously, the treatment completely abolished the IFN-γ-induced upregulation of PD-L1 and PD-L2 in all three tested cell lines (Figure 1A,B). The gene discussed is PDCD1LG2; the disease is melanoma.